Bacillus marasmi CN1234
publication ID |
https://doi.org/ 10.12651/JSR.2023.12 |
persistent identifier |
https://treatment.plazi.org/id/5C70BA07-FF88-FF98-FCEC-FB52D4E2E7B2 |
treatment provided by |
Felipe |
scientific name |
Bacillus marasmi CN1234 |
status |
|
Description of Bacillus marasmi CN1234
Cells are Gram-staining-positive, flagellated, and rod-shaped with 0.7-0.8 × 1.6-1.8 μm in size. Colonies are smooth, translucent and white colored after three days of incubation at 30℃ on R2A. The strain is positive for reduction of nitrates to nitrite, glucose acidification, β -ga- lactosidase (PNPG), assimilation of D- glucose, L- arabi- nose, D- mannose, D- mannitol, N -acetyl-D- glucosamine, D- maltose, gluconate, and malate; but negative for indole production, arginine dihydrolase, urease, β -glucosi- dase (esculin hydrolysis), protease (gelatin hydrolysis), caprate, adipate, citrate, and phenyl-acetate. The strain utilizes D- mannitol, D- glucose, D- melibiose, L- fucose, 2-ketogluconate, L- proline, L- rhamnose, N -acetyl-D- glu- cosamine, D- ribose, D- maltose, acetate, lactate, L- alanine, glycogen, and L- serine; but does not utilize salicin, D- sor- bitol, propionate, caprate, valerate, citrate, L- histidine, 3-hydroxy-butyrate, 4-hydroxy-benzoate, inositol, D- su- crose, itaconate, suberate, malonate, 5-ketogluconate, and 3-hydroxy-benzoate. The strain produces alkaline phosphatase, leucine arylamidase, valine arylamidase, trypsin, acid phosphatase, naphtol-AS-BI-phosphohydrolase, β -galactosidase, β -glucuronidase, α -glucosidase, and cystine arylamidase (weak); but does not produce esterase (C4), esterase lipase (C8), lipase (C14), α -chymotrypsin, α -galactosidase, β -glucosidase, N -acetyl- β -glucosamin- idase, α -mannosidase, and α -fucosidase. Strain CN1234 (= NIBRBAC000506105) was isolated from a paddy soil sample, Taean County, Korea.
No known copyright restrictions apply. See Agosti, D., Egloff, W., 2009. Taxonomic information exchange and copyright: the Plazi approach. BMC Research Notes 2009, 2:53 for further explanation.